Cargando…

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19

Detalles Bibliográficos
Autores principales:	Benedetti, María Fernanda, de Abreu, Mariela Soledad, Cadena, Roberto Corella, Arias, María Constanza, Posse, Gladys, Capece, Paula, Nusblat, Alejandro, Cuestas, María Luján
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SFMM. Published by Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801853/ https://www.ncbi.nlm.nih.gov/pubmed/35123158 http://dx.doi.org/10.1016/j.mycmed.2022.101251

Ejemplares similares

COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina
por: Benedetti, María Fernanda, et al.
Publicado: (2020)

Invasive fusariosis in a critically ill patient with severe COVID-19 pneumonia: A case report
por: Barberis, Fernanda, et al.
Publicado: (2021)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Invasive Aspergillosis and Candidiasis in a Patient with Plasma Cell Myeloma
por: Khadwal, Alka, et al.
Publicado: (2023)

Sporothrix brasiliensis: A Review of an Emerging South American Fungal Pathogen, Its Related Disease, Presentation and Spread in Argentina
por: Etchecopaz, Alejandro, et al.
Publicado: (2021)

Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia
por: Miesel, Lynn, et al.
Publicado: (2021)

COVID-19: Ecos de una pandemia
por: Cuestas, María Luján, et al.
Publicado: (2020)

Virus emergentes y reemergentes: un nuevo reto para la salud mundial del milenio
por: Cuestas, María Lujan, et al.
Publicado: (2020)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021)

Invasive candidiasis as a cause of sepsis in the critically ill patient
por: Delaloye, Julie, et al.
Publicado: (2014)

What’s new in invasive pulmonary aspergillosis in the critically ill
por: Koulenti, Despoina, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
por: Rayens, Emily, et al.
Publicado: (2022)

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
por: Ruhnke, M, et al.
Publicado: (2012)

Candidiasis vaginal
por: Robles Soberano, María del Carmen
Publicado: (2011)

Critical appraisal beyond clinical guidelines for intraabdominal candidiasis
por: Maseda, Emilio, et al.
Publicado: (2023)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy
por: Miesel, Lynn, et al.
Publicado: (2019)

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis
por: Giacobbe, Daniele R., et al.
Publicado: (2021)

CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis
por: Hong, Wonju, et al.
Publicado: (2022)

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
por: Trof, R. J., et al.
Publicado: (2007)

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
por: Tissot, Frederic, et al.
Publicado: (2017)

Invasive pulmonary aspergillosis with candidiasis: usefulness of molecular and ultrastructural morphological analysis on FFPE tissue for invasive fungal infections
por: Kubota, Yusaku, et al.
Publicado: (2023)

Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines
por: Ahmed, Armin, et al.
Publicado: (2015)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

Disseminated enteroinvasive aspergillosis in a critically ill patient without severe immunocompromise
por: Fieber, Jennifer H., et al.
Publicado: (2013)

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
por: Lamoth, Frederic, et al.
Publicado: (2020)

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2020)

Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016)

The Impacts of Aspergillosis on Outcome, Burden and Risks for Mortality in Influenza Patients with Critical Illness
por: Chao, Chien-Ming, et al.
Publicado: (2021)

A Comparison of Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Critically Ill Patients
por: Liu, Rui-ting, et al.
Publicado: (2023)

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin – case study and brief literature review
por: Barańska, Marta, et al.
Publicado: (2017)

1272. Efficacy of a Non-Peptide, Small Molecule Mimic of Host Defense Proteins in Mouse Models of Disseminated Candidiasis and Aspergillosis
por: Scott, Richard W, et al.
Publicado: (2020)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Invasive aspergillosis in critically ill hematology patients: outcomes and prognostic factors associated with mortality
por: Burghi, G, et al.
Publicado: (2011)

Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
por: Taccone, Fabio Silvio, et al.
Publicado: (2015)

Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study
por: Waldeck, Frederike, et al.
Publicado: (2020)

1175. Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
por: Mitaka, Hayato, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ib9q7ni68ehg3096jr34mtr5gf